SEC Form 4 · accession 0001526335-15-000001
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Brian J. Underdown
Director
Period of report
Jun 17, 2015
Accepted (ET)
Jun 18, 2015 · 10:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.80 | Jun 17, 2015 | A | 5,500 | A | — | Jun 16, 2025 | Common Stock | 5,500 | 16,500 | D |
Explanation of responses
- F1This option was granted on June 17, 2015 and vests in equal amounts quarterly over the 12 month period beginning June 17, 2015.